AZ, Ionis Shares Tumble on ATTR‑CM Trial Flop, But Analyst Flags Over‑Reaction Explained on July 09, 2026 Alnylam AstraZeneca ATTR-CM CARDIO-TTRansform trial cardiovascular deaths Eplontersen heart events Ionis Pharmaceuticals Market over-reaction Reaction selloff transthyretin-mediated amyloid cardiomyopathy Wainua +